Vaxcyte, Inc. (PCVX)
46.85
+0.52
(+1.12%)
USD |
NASDAQ |
Jun 09, 16:00
46.86
0.00 (0.00%)
After-Hours: 19:05
Vaxcyte Shareholders Equity (Quarterly) : 2.996B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | 607.69M |
| Revolution Medicines, Inc. | 1.500B |
| Vera Therapeutics, Inc. | 499.70M |
| Erasca, Inc. | 393.53M |
| Arrowhead Pharmaceuticals, Inc. | 613.98M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.348B |
| Total Liabilities (Quarterly) | 352.29M |
| Debt to Equity Ratio | 0.0388 |
| Current Ratio | 7.491 |
| Net Debt Paydown Yield | -0.11% |